NCT06442826

Brief Summary

In Spain, depression, anxiety, and stress are highly prevalent in the general population as well as in college students. In college students, Ramón Arbués et al. found a moderate prevalence of depression (18.4%), anxiety (23.6%) and stress (34.5%). It is essential to take responsibility for promoting health education, disease prevention, protection and care for young people. Academic performance can be altered due to the stressful nature of exam situations, which can lead to increased anxiety and decrease expected performance, mainly due to effects such as decreased attention span, concentration and retention of information. Modulation of vagal tone is a therapeutical strategy to heightened parasympathetic activity and withdrawal sympathetic activity. Auricular transcutaneous VNS (ATVNS) by which parasympathetic nerve system is modulated by means of the stimulation of the auricular branch of the vagus nerve that provides somatosensory innervation to the external ear. It has been shown that there are different effective interventions to reduce the symptoms of stress, depression, anxiety and insomnia in university students, but they are based on psychological interventions or face-to-face and cognitive-behavioral therapeutic approach, so this study proposal incorporates noninvasive atrial stimulation as an alternative to traditional treatments, which apart from being cost-effective, is easy to apply, well tolerated and presumably can have beneficial effects in the short term. In the present pilot study, authors propose to investigate the degree of depression, anxiety and stress on crucial dates of final exams of 1st year students of the Double Degree Physiotherapy - Physical Activity and Sport Sciences of the Health Department of the TecnoCampus. Investigators will also evaluate the feasibility of a study to assess the efficacy of a non-pharmacological intervention, through a neuroreflex stimulation of vagal tone, with a non-invasive atrial stimulation protocol.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable anxiety

Timeline
Completed

Started May 2024

Shorter than P25 for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2024

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

May 30, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 4, 2024

Completed
17 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 21, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 21, 2024

Completed
Last Updated

November 22, 2024

Status Verified

June 1, 2024

Enrollment Period

2 months

First QC Date

May 30, 2024

Last Update Submit

November 19, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Recruitment strategy effectiveness

    o evaluate the effectiveness of our recruitment strategy, we will analyze several key metrics, including the number of eligible participants, the number who expressed interest by completing the initial form, the participants who proceeded to the initial interview, and finally, the number of students who enrolled in the study. Additionally, we will carefully examine the reasons provided by students who declined to participate, allowing us to refine our recruitment approach.

    Week 0

  • Safety and Tolerability

    Any side effects that may arise during the study will be meticulously monitored, and their frequency and severity will be assessed based on patients' self-reports. These side effects will be categorized as either minor, relevant, or important according to the patients' descriptions and assessments. Additionally, we will maintain a record of the number of participants who chose to remove at least one of the patches due to the side effects they experienced

    Week 2

Secondary Outcomes (10)

  • Exclusion rate

    Week 0

  • Dropout rate

    Week 2

  • Compliance to the intervention protocol

    Week 2

  • Data collection feasibility

    Week 2

  • Participant blinding success:

    Week 2

  • +5 more secondary outcomes

Study Arms (3)

True non-invasive auricular stimulation (TniAS)

EXPERIMENTAL

Ear stimulation using true ear patches

Other: Non-invasive auricular stimulation

Sham auricular stimulation (SAS)

PLACEBO COMPARATOR

Ear stimulation using sham ear patches

Other: Sham auricular stimulation (SAS)

No-intervention group (NI)

NO INTERVENTION

Participants in the No-Intervention group (NI) will not receive any active intervention as part of the trial.

Interventions

Single session TniAS stimulation will be achieved by applying four stimulation patches. These patches consist of stainless steel spheres with a diameter of 1.2 mm, covered with adhesive circular paper measuring 8 mm in diameter. Point 1. Located in the Triangular Fossa, upper and central level at the vertex of the Fossa, at junction between the upper root and the lower root of the Antihelix. Point 2. Located in the inner part of the Cymba (upper) conchae, in the angle formed by the lower root of the antihelix and the ascending branch of the Helix. Point 3. Located in the middle depression of the Cavum (lower) conchae. Poinit 4. It is located at the inner superior quadrant of Lobe, below the external curve of the Intertragus notch, in a depression 3-4 mm from the insertion of the lobe to the face.

True non-invasive auricular stimulation (TniAS)

Sham intervention will be conducted following the exact same procedure as the TniAS group, with the only difference being the use of sham stimulation patches. These sham patches will consist of the same patches utilized in the TniAS group, except for the absence of the stainless steel spheres. During the application of these sham patches, the investigator will adhere to the identical process as in the TniAS group, with the exception that no palpation will be performed to locate the exact points, and only minimal pressure required for patch adherence will be applied to minimize any substantial stimulation. Participants in the SAS group will also be explicitly instructed not to stimulate the points until the removal of the patches. The removal of the sham stimulation patches will follow the precise protocol applied in the TniAS group, ensuring consistency in the study procedures across both groups.

Sham auricular stimulation (SAS)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • At least 18 years old
  • Tecnocampus undergraduate students from Physical Therapy and Sports Science Double Degree of 1rst course.
  • To sign the informed consent
  • Understand Catalan or Spanish language
  • With the intention to attend to the first call exams of the 2nd trimester.

You may not qualify if:

  • Receiving pharmacological medication for anxiety or mental disorders
  • Receiving psychological treatment
  • Pregnancy or breastfeeding
  • Participants with part-time enrolment
  • With skin lesions in both auricula,
  • Participating in another study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tecnocampus

Mataró, Barcelona, 08302, Spain

Location

MeSH Terms

Conditions

Anxiety DisordersSleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Mental DisordersSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 30, 2024

First Posted

June 4, 2024

Study Start

May 1, 2024

Primary Completion

June 21, 2024

Study Completion

June 21, 2024

Last Updated

November 22, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations